Non-Invasive Surgical Wound Closure Market

Non-Invasive Surgical Wound Closure Market Analysis

The Non-Invasive Surgical Wound Closure Market size is estimated at USD 6.23 billion in 2025, and is expected to reach USD 8.07 billion by 2030, at a CAGR of 5.3% during the forecast period (2025-2030).

Several key factors drive the non-invasive surgical wound closure market. Among the main drivers are the rising demand for minimally invasive surgical procedures, the rising popularity of scar-free aesthetic results, improvements in wound closure technology, and the rising number of chronic illnesses and trauma cases requiring surgical interventions. These drivers are expected to fuel the market’s growth during the forecast period.

The rise in the number of trauma cases leads to a higher demand for wound closure products, including non-invasive options. This growing prevalence can be considered as one of the crucial drivers for the growth of this market. For instance, according to one of the reports released by the World Health Organization (WHO) in December 2023, 20 to 50 million individuals experienced non-fatal injuries, often resulting in disabilities in 2022. This significant number reflects the increased demand for surgical procedures as well. Trauma cases often result in various types of wounds, ranging from minor to severe, and the choice of wound closure method can depend on the nature and extent of the injury. Therefore, these factors are expected to boost the growth of this market.

Apart from this, the surge in aesthetic procedures is expected to propel the demand for non-invasive wound closure products, thereby boosting market growth during the forecast period. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) statistics published in June 2024, liposuction remained the most common surgical procedure, with over 2.2 million operations. Further, the cosmetic industry experienced a significant rise in facial and head procedures, totaling over 6.5 million, reflecting a 19.6% increase in 2023.

As per the same source, the most popular treatments included eyelid surgeries, exceeding 1.7 million, rhinoplasties at 1.1 million, and lip enhancements/perioral procedures at 0.9 million. Additionally, there were 4.1 million breast procedures and 5.1 million body and extremity treatments performed in 2023. Patients increasingly seek procedures that result in minimal scarring, particularly in visible or cosmetically sensitive areas like the face, neck, and hands. This demand drives healthcare professionals to explore non-invasive wound closure options that can achieve better cosmetic results compared to traditional sutures or staples. Also, the shift toward minimally invasive surgical procedures is propelling the growth of this market.

Additionally, advancements in technology have significantly impacted the non-invasive surgical wound closure market, leading to improved patient outcomes, reduced recovery times, and enhanced overall healthcare practices. The development of advanced adhesive materials, such as biocompatible and bioabsorbable glues, tapes, and sealants, has revolutionized wound closure techniques. For instance, Futura Surgicare Pvt Ltd, which operates through Dolphin Sutures, launched a Hemostatic product under the brand Hemostax (oxidized regenerated cellulose), categorized in a new vertical Dolphin Hemostats in February 2022. It is a topical adhesive used for the closure of surgical wounds. Therefore, advancements in technology for non-invasive surgical wound closure are anticipated to fuel the growth of the market during the forecast period.

Therefore, owing to factors such as the rise in the number of trauma cases, advancements in technology, and a surge in aesthetic procedures, this market is anticipated to witness growth in the coming years. However, factors like stringent regulatory guidelines and the high cost associated with advanced non-invasive surgical wound closure products limit the growth of the market.

Non-Invasive Surgical Wound Closure Market Trends

The Adhesives Segment is Expected to Hold a Significant Market Share Over the Forecast Period

• Adhesives offer a less invasive and virtually painless alternative to traditional wound closure methods such as sutures and staples. Patients often prefer adhesive-based closures as they avoid the discomfort associated with needle and thread or metal staples. Adhesives can facilitate faster wound closure. They are easy to apply and require less time than sutures or staples, reducing the overall duration of surgery and potentially lowering the risk of infection. All these characteristics make the adhesives segment the dominant market.
• Furthermore, as the use of tissue adhesives rises, there is a corresponding surge in demand for non-invasive methods of surgical wound closure. Tissue adhesives offer several advantages over traditional methods, such as sutures or staples, including reduced procedure time, minimal tissue trauma, and improved cosmetic outcomes. For instance, an article published by Springer Nature in June 2023 stated that the development of new tissue adhesives (TAs) for various applications has garnered significant attention. These adhesives offer benefits such as shorter surgery times, less pain, leakage prevention, and the avoidance of removal procedures. Due to the discomfort that can be caused by sutures, there has been increased interest in sutureless methods for wound closure, despite sutures being widely used due to their simplicity and quick application. Therefore, as more healthcare providers recognize these benefits, there is a growing preference for non-invasive techniques, which in turn drives the demand for products in the non-invasive surgical wound closure market.
• There has been an increase in product approvals and launches concerning the adhesive segment. This is something that can be considered as a boosting factor for the market. For instance, in February 2023, 3M launched a new medical adhesive. It was an advanced medical adhesive that could stick to the skin for up to 28 days. This reflects the strategies of the companies to improvise their adhesive product portfolio. This would help in propelling the growth of this segment in the forecasted period.
• Adhesives are less likely to cause allergic reactions compared to some suture materials, which can be made from materials like silk or metal. This can be particularly important for patients who are sensitive or have allergies. These factors contribute to the significant share of adhesives in this market and are expected to boost the growth of the market during the forecast period.

North America is Expected to Hold a Significant Market Share During the Forecast Period

• During the forecast period, North America is anticipated to register a substantial growth rate in the non-invasive surgical wound closure market. This can be linked to elements like the rise in surgical procedures and the growing population of elderly people.
• The overall rise in surgical procedures, including both elective and non-elective surgeries, is a significant driver for the non-invasive surgical wound closure market. As per one of the articles published by Vianam Healthtech Private Limited in July 2023, approximately 2,00,000 heart bypass surgeries are performed in the United States in a year. Similarly, according to the University of Ottawa Heart Institute, in October 2023, this heart institute had around 1,900 heart procedures performed annually in Canada. The market for non-invasive surgical wound closure is rising in this region as a result of preferences for non-invasive options and the rising number of surgical procedures performed in North America. Patients and healthcare providers alike prefer less invasive procedures, and non-invasive wound closure methods align well with this trend.
• The rise in the number of product approvals through the US FDA fuels the growth of the market in this region. For instance, Advanced Medical Solutions Group PLC's LiquiBand XL, a novel device that can cover longer wounds than conventional LiquiBand products, was granted FDA 510(k) approval in May 2022. The device consists of LiquiBand glue to reinforce the closure and stop infection, together with surgical mesh to close the wound. Developments like these are expected to boost the growth of this market in North America.
• Therefore, the market studied is expected to expand in North America as a result of the aforementioned factors, such as the rising number of surgical procedures and the surge in the number of product approvals in this region.

Non-Invasive Surgical Wound Closure Industry Overview

With a large number of participants, the non-invasive surgical wound closure market is extremely fragmented. The dominant players in this industry are heavily engaged in acquisitions, expansions, product approvals, and other tactics. Some market players are Johnson and Johnson (Ethicon), 3M, Smith+Nephew, and Medtronic.

Non-Invasive Surgical Wound Closure Market Leaders

Non-Invasive Surgical Wound Closure Market News

• April 2024: LifeScience PLUS launched its innovative new product, a hemostatic wound healing solution for treating donor sites, at the 56th Annual American Burn Association (ABA) Meeting held in Chicago.
• July 2023: Baxter launched PERCLOT Absorbable Hemostatic Powder in the United States, which expanded its portfolio of hemostats. PERCLOT is an absorbable hemostatic powder, ready for use, designed to passively address mild bleeding in patients with intact coagulation.